Keytruda Post-Launch Patient Website

Brand: Keytruda (pembrolizumab), Injection
Parent Company: Merck
Drug Type: Prescription
Drug Category: Oncology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.keytruda.com/
HCP Website: https://www.keytruda.com/hcp/